Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mukta Arora

Showing results (91-100 of 168) with videos related to

Pageof 17
Sort By:
Blood Advances|June 24, 2020
Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomesRebecca L Olin, Caitrin Fretham, Marcelo C Pasquini, et al.
Transplantation and Cellular Therapy|June 14, 2021
Relevance of Plasma Matrix Metalloproteinase-9 for Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell TransplantationYoshihiro Inamoto, Paul J Martin, Lynn E Onstad, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 15, 2015
Marrow damage and hematopoietic recovery following allogeneic bone marrow transplantation for acute leukemias: Effect of radiation dose and conditioning regimenChristopher Wilke, Shernan G Holtan, Leslie Sharkey, et al.
Cancer|August 15, 2019
Late mortality after bone marrow transplant for chronic myelogenous leukemia in the context of prior tyrosine kinase inhibitor exposure: A Blood or Marrow Transplant Survivor Study (BMTSS) reportJessica Wu, Yanjun Chen, Lindsey Hageman, et al.
Blood|September 20, 2017
Ibrutinib for chronic graft-versus-host disease after failure of prior therapyDavid Miklos, Corey S Cutler, Mukta Arora, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 8, 2009
Allogeneic hematopoietic cell transplant for prolymphocytic leukemiaMatt E Kalaycio, Manisha Kukreja, Ann E Woolfrey, et al.
Haematologica|April 3, 2016
Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adultsRohtesh S Mehta, Regis Peffault de Latour, Todd E DeFor, et al.
Transplantation and Cellular Therapy|October 14, 2020
Prophylactic Foscarnet for Human Herpesvirus 6: Effect on Hematopoietic Engraftment after Reduced-Intensity Conditioning Umbilical Cord Blood TransplantationNajla El Jurdi, John Rogosheske, Todd DeFor, et al.
Blood Advances|September 17, 2021
Initial therapy for chronic graft-versus-host disease: analysis of practice variation and failure-free survivalJoseph Pidala, Lynn Onstad, Paul J Martin, et al.
Blood|April 26, 2003
Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter studyGorgun Akpek, Stephanie J Lee, Mary E Flowers, et al.
Pageof 17

Showing results (91-100 of 168) with videos related to

Sort By:
Pageof 17
Blood Advances|June 24, 2020
Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomesRebecca L Olin, Caitrin Fretham, Marcelo C Pasquini, et al.
Transplantation and Cellular Therapy|June 14, 2021
Relevance of Plasma Matrix Metalloproteinase-9 for Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell TransplantationYoshihiro Inamoto, Paul J Martin, Lynn E Onstad, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 15, 2015
Marrow damage and hematopoietic recovery following allogeneic bone marrow transplantation for acute leukemias: Effect of radiation dose and conditioning regimenChristopher Wilke, Shernan G Holtan, Leslie Sharkey, et al.
Cancer|August 15, 2019
Late mortality after bone marrow transplant for chronic myelogenous leukemia in the context of prior tyrosine kinase inhibitor exposure: A Blood or Marrow Transplant Survivor Study (BMTSS) reportJessica Wu, Yanjun Chen, Lindsey Hageman, et al.
Blood|September 20, 2017
Ibrutinib for chronic graft-versus-host disease after failure of prior therapyDavid Miklos, Corey S Cutler, Mukta Arora, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 8, 2009
Allogeneic hematopoietic cell transplant for prolymphocytic leukemiaMatt E Kalaycio, Manisha Kukreja, Ann E Woolfrey, et al.
Haematologica|April 3, 2016
Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adultsRohtesh S Mehta, Regis Peffault de Latour, Todd E DeFor, et al.
Transplantation and Cellular Therapy|October 14, 2020
Prophylactic Foscarnet for Human Herpesvirus 6: Effect on Hematopoietic Engraftment after Reduced-Intensity Conditioning Umbilical Cord Blood TransplantationNajla El Jurdi, John Rogosheske, Todd DeFor, et al.
Blood Advances|September 17, 2021
Initial therapy for chronic graft-versus-host disease: analysis of practice variation and failure-free survivalJoseph Pidala, Lynn Onstad, Paul J Martin, et al.
Blood|April 26, 2003
Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter studyGorgun Akpek, Stephanie J Lee, Mary E Flowers, et al.
Pageof 17